NINJ1

Yu Zhao1, Da Qin1, Xiangji Li2

  • 1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing, China.

Discover oncology
|May 11, 2024
PubMed
概括

NINJ1是一种新型的预后生物标志物,用于逆皮质脂肪肉瘤 (RPLS). 在RPLS患者中,更高的NINJ1表达与改善的整体存活率 (OS) 和无病存活率 (DFS) 相相关,有助于治疗和药物开发.